Form 4: OS Therapies Director Granted 50,000 Stock Options

Theodore F. Search, a Director and 10% owner of OS Therapies Inc., was granted options to purchase 50,000 shares of common stock.

Summary

• Theodore F. Search, a Director and 10% owner of OS Therapies Inc. (OSTX), was granted options to purchase 50,000 shares of the company's common stock on January 22, 2026.
• These options have an exercise price of $1.34 per share and are set to expire on January 22, 2036.
• The options will vest in full on January 22, 2027, provided Mr. Search continues to serve as a director on that date.
• Following this transaction, Mr. Search directly owns 20,000 shares of common stock and 50,000 stock options.
• He also indirectly beneficially owns 435,835 shares of common stock through Mill River Partners LLC, where he serves on the board of managers and shares voting and investment power.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it represents standard director compensation and aligns the director's interests with long-term shareholder value, without indicating any significant operational or financial changes.

Positives

• The grant of 50,000 stock options to a director aligns his interests with long-term shareholder value and incentivizes continued service.

Risks

• The vesting of the 50,000 stock options is contingent upon Theodore F. Search serving as a director of OS Therapies Inc. on the one-year anniversary of the grant date (January 22, 2027).

Future Outlook

The 50,000 stock options granted to Director Theodore F. Search are set to vest in full on January 22, 2027, contingent on his continued service as a director.

Industry Context

StockSavvy.ai notes that equity grants to directors are a standard practice in the biotechnology and pharmaceutical industries, aiming to align leadership incentives with long-term company performance and shareholder interests. This grant to a 10% owner and director of OS Therapies Inc. is consistent with typical corporate governance practices for retaining and motivating key personnel.

Related Party Transactions

• Theodore F. Search indirectly beneficially owns 435,835 shares of common stock through Mill River Partners LLC, where he serves on the board of managers and shares voting and investment power.

Stakeholder Impact

• Shareholders: The grant of stock options to a director can align management incentives with shareholder interests, potentially encouraging long-term value creation.
• Employees: No direct impact on general employees is indicated.
• Customers: No direct impact on customers is indicated.
• Suppliers: No direct impact on suppliers is indicated.
• Creditors: No direct impact on creditors is indicated.

Next Steps

• The 50,000 stock options are expected to vest on January 22, 2027, assuming Theodore F. Search remains a director.

Key Dates

Recommendation

This Form 4 filing reports a routine equity grant to a director and does not contain sufficient information to warrant a change in investment recommendation. It primarily serves as a disclosure of insider activity, which is generally expected for director compensation.

Keywords

OS Therapies Inc, OSTX, Form 4, Insider Transaction, Stock Options, Director Compensation, Beneficial Ownership, Equity Grant